Related Articles
Cyclooxygenase‑2 induces angiogenesis in pancreatic cancer mediated by prostaglandin E2
Effects of combining Taxol and cyclooxygenase inhibitors on the angiogenesis and apoptosis in human ovarian cancer xenografts
Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H22 murine hepatocarcinoma model
Antitumor effect of the selective COX-2 inhibitor celecoxib on endometrial adenocarcinoma in vitro and in vivo
Norcantharidin: A potential antiangiogenic agent for gallbladder cancers in vitro and in vivo